Mary Ramirez, MD
Dermatology · San Antonio, TXNPI 1841686987
Payments from drug & device makers
Across 522 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Galderma Laboratories, L.p.$2K
- Johnson & Johnson$1K
- Regeneron Healthcare Solutions, Inc.$937
- Dermavant Sciences, Inc.$672
- Incyte Corporation$642
- plus $5K from 27 others
What the payments were for
- Food & beverage$10,74795%
- Education$6135%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $1,659 |
| Galderma Laboratories, L.p. | 71 | $1,554 |
| Johnson & Johnson | 41 | $1,009 |
| Regeneron Healthcare Solutions, Inc. | 45 | $937 |
| Dermavant Sciences, Inc. | 49 | $672 |
| Incyte Corporation | 27 | $642 |
| Lilly USA, LLC | 28 | $604 |
| E.r. Squibb & Sons, L.L.C. | 24 | $568 |
| Sanofi | 17 | $446 |
| LEO Pharma Inc. | 18 | $375 |
| Novartis | 16 | $310 |
| Pfizer | 16 | $279 |
| Arcutis Biotherapeutics, Inc. | 14 | $258 |
| Revance Therapeutics, Inc. | 3 | $257 |
| UCB, Inc. | 7 | $236 |
| Sun Pharmaceutical Industries Inc. | 11 | $196 |
| Almirall LLC | 12 | $190 |
| Krystal Biotech Inc | 9 | $174 |
| Organon | 6 | $171 |
| Nobelpharma America, LLC | 1 | $140 |
| Amgen | 5 | $129 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $124 |
| Biofrontera Inc. | 4 | $76 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Fresenius Kabi USA, LLC | 3 | $71 |
| Organogenesis Inc. | 1 | $44 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $39 |
| VYNE Pharmaceuticals Inc. | 2 | $34 |
| Merz North America, Inc. | 1 | $34 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $22 |
| LNHC, Inc | 1 | $16 |
| Journey Medical Corporation | 1 | $13 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,361 in reported general payments places this provider in the 70th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 25 | $92,824 |
| Clobetasol Propionate | 103 | $3,877 |
| Tacrolimus | 22 | $2,549 |
| Ketoconazole | 107 | $1,742 |
| Fluorouracil | 23 | $1,542 |
| Triamcinolone Acetonide | 104 | $1,052 |
| Clindamycin Phosphate | 37 | $974 |
| Metronidazole | 14 | $791 |
| Tretinoin | 11 | $784 |
| Nystatin | 31 | $543 |
| Hydrocortisone | 19 | $277 |
| Latanoprost | 29 | $250 |
| Mupirocin | 26 | $223 |
| Doxycycline Hyclate | 15 | $206 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Antonio
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Emily BeckerSan Antonio$2.4M
- William CragunSan Antonio$2.3M
- Steven DavisSan Antonio$1.8M
- Lindsey FinkleaSan Antonio$1.2M
- Stephen MillerSan Antonio$389K
- Vivian BucaySan Antonio$241K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.